Patent Assignment
Reel/Frame 016854/0262
Corrective Name Change to Correct Assignee's Name Previously Recorded at Reel 016378 Frame 0443.
Recorded: 2005-10-05
Pages: 22
Assignor
RIBOZYME PHARMACEUTICALS, INC.
Executed: 2003-04-16
Assignee
SIRNA THERAPEUTICS, INC.
2950 WILDERNESS PLACE, BOULDER, COLORADO, 80301
Covered Property
(1)
Enzymatic Nucleic Acid-Mediated Treatment of Ocular Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (Vegf-R)
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2002
From: PAVCO, PAMELA; MCSWIGGEN, JAMES; STINCHCOMB, DAN
To: RIBOZYME PHARMACEUTICALS, INC.
Reel/Frame 013182/0220 →
Assignment of Assignor's Interest
Aug 13, 2002
From: ESCOBEDO, JAIME
To: CHIRON CORPORATION, INC.
Reel/Frame 013182/0308 →
Change of Name
Mar 21, 2005
From: RIBOZYME PHARMACEUTICALS, INC.
To: SIRNA THERAPEUTICS, CIN
Reel/Frame 016378/0443 →